Which calculators, nomograms, or other resources, if any, do you use to help advise and prognosticate patients with newly diagnosed glioblastoma or other gliomas?

This is a rather difficult question to answer because prognosis in patients with glioblastoma (GBM) is best estimated by combining several clinical, molecular, radiographic, and treatment-related factors rather than relying on any single variable. Several validated prognostic models exist, but in cl...

I think it is important to know the average prognosis for methylated versus unmethylated disease (in Stupp, median OS for MGMT methylated was ~ 21 months vs 12 for unmethylated), but there is not a nomogram or algorithm specifically that I use to prognosticate. I emphasize routinely to patients that...